Spiriva
(Tiotropium Bromide)ApprovedSmall molecule
Boehringer IngelheimTiotropium bromide is used to treat chronic obstructive pulmonary disease (COPD) and asthma by helping to relax and open airways in the lungs, making it easier to breathe.[2] Spiriva is currently approved and in use across 13 indications[4].[1]
Spiriva is one of 282 small molecule programs targeting Emphysema. It is currently in Approved.
13
Indications
51
Total Trials
0
Active Trials
281
Competitors
Pipeline
Status by Indication[4][1]
Indication
Showing 10 of 12 indications
Competition
Competitive Landscape
1050 competitors in Asthma
#DrugCompanyPhaseTrials
1Spiriva
Boehringer IngelheimApproved
Veramyst
GSKPreclinical
Dupixent
AAzienda U.S.L. 1 di Massa e Carrara
Preclinical
Celexa
AbbViePreclinical
Arcoxia
NovartisPreclinical
Decadron
QQuince Therapeutics S.p.A.
Preclinical
Blood Withdrawn
Emergent BioSolutionsPreclinical
Aclidinium Bromide
AstraZenecaPreclinical
Spiriva
Boehringer IngelheimPreclinical
Guanidine Hydrochloride
CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Chronic Obstructive Pulmonary Disease15 trials
Show 12 more trials
Asthma8 trials
The Effects of Different Long-acting Bronchodilator Medications on Asthma Patients With Different Genetic Variations
Terminated·—·N/A·NCT00706446·255 enrolled
Show 5 more trials
COPD3 trials
Tiotropium Handihaler vs. Tiotropium Respimat in COPD
Withdrawn·—·Phase 2·NCT05838703
Efficacy and Safety2 trials
COPD Exacerbation2 trials
18 more indications
Tolerance2 trials
Treatment1 trial
Quality of Life1 trial
Atopic Asthma1 trial
Dyspnea1 trial
Salmeterol1 trial
Cystic Fibrosis1 trial
Cardiovascular Disease1 trial
Unspecified3 trials
Methacholine, Long-acting M-cholinolytic and beta2-agonist on the Activity of Beta-receptors in Healthy Volunteers
Unknown status·—·N/A·NCT04137029·20 enrolled
Sources
References
- [1]
- [2]MedlinePlus Drug Information — Spiriva drug information. U.S. National Library of Medicine, National Institutes of Health.
- [3]
- [4]Open Targets Platform — Drug–disease associations for Tiotropium Bromide. EMBL-EBI & Wellcome Sanger Institute.
- [5]
Details
Drug Info
Quick Facts
- Mechanism of Action
- Muscarinic Acetylcholine Receptor M3 Antagonist[3]
- Modality
- Small molecule[3]
- Highest Phase
- Approved[1]
- Company